Glycopyrrolate, Formoterol, Fluticasone Propionate

Glycopyrrolate, Formoterol, and Fluticasone Propionate are three active ingredients combined in a single medication to effectively manage chronic obstructive pulmonary disease (COPD) and asthma symptoms.
Glycopyrrolate is an anticholinergic agent that works by blocking the action of acetylcholine, a neurotransmitter responsible for muscle contractions in the airways. This helps to relax the muscles and reduce the frequency of bronchospasms, thereby improving airflow and reducing symptoms such as wheezing, shortness of breath, and coughing.
Formoterol is a long-acting beta-agonist (LABA) that works by relaxing and opening the airways, making it easier to breathe. It also helps to prevent bronchoconstriction caused by exercise or other triggers. Formoterol provides long-lasting relief, with its effects lasting up to 12 hours.
Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways, making it easier to breathe. It works by inhibiting the release of inflammatory mediators, such as histamine and leukotrienes, which cause airway constriction and mucus production.
The combination of Glycopyrrolate, Formoterol, and Fluticasone Propionate is designed to provide comprehensive relief from COPD and asthma symptoms, including wheezing, shortness of breath, coughing, and chest tightness. This medication is typically prescribed for patients who require ongoing treatment to manage their symptoms and improve their quality of life. Follow the prescribed dosage and schedule, and to consult with a healthcare professional before making any changes to the treatment plan.